Genscript Biotech's total assets for Q4 2025 were $4.85B, a decrease of -10.71% from the previous quarter. HK:1548 total liabilities were $876.30M for the fiscal quarter, a -13.52% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.